Capivasertib

Overview

Capivasertib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2325741).

API suppliers (1)

Suppliers of Capivasertib backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Forest Laboratories, Inc.United States1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (2 approved US products), the latest listed US patent on Capivasertib expires 16 Apr 2033 and exclusivity 12 Jun 2029. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide

Canonical SMILES

C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4

InChIKey

JDUBGYFRJFOXQC-KRWDZBQOSA-N